Doximity (NASDAQ:DOCS) Coverage Initiated at Stephens

Stock analysts at Stephens started coverage on shares of Doximity (NASDAQ:DOCS) in a research report issued on Friday,Briefing.com Automated Import reports. The firm set an “equal weight” rating and a $55.00 price target on the stock. Stephens’ target price suggests a potential downside of 0.33% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the stock. Morgan Stanley raised shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Truist Financial raised their price objective on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research note on Thursday, November 14th. Canaccord Genuity Group lowered Doximity from a “buy” rating to a “hold” rating and boosted their target price for the company from $40.00 to $60.00 in a research note on Wednesday, November 13th. Evercore ISI raised their price target on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, The Goldman Sachs Group began coverage on Doximity in a research note on Friday, November 15th. They issued a “neutral” rating and a $58.00 price target on the stock. Thirteen analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $52.59.

Doximity Trading Up 5.7 %

DOCS opened at $55.18 on Friday. The stock has a market capitalization of $10.30 billion, a P/E ratio of 63.43, a PEG ratio of 4.16 and a beta of 1.40. Doximity has a 12-month low of $22.96 and a 12-month high of $61.75. The stock has a 50-day moving average price of $48.82 and a 200-day moving average price of $38.57.

Institutional Investors Weigh In On Doximity

Several hedge funds have recently bought and sold shares of the business. MetLife Investment Management LLC boosted its position in shares of Doximity by 0.6% in the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after purchasing an additional 363 shares in the last quarter. First Horizon Advisors Inc. increased its position in shares of Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock valued at $91,000 after acquiring an additional 384 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after buying an additional 412 shares during the last quarter. Van ECK Associates Corp increased its holdings in Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after buying an additional 427 shares in the last quarter. Finally, Cornercap Investment Counsel Inc. lifted its stake in Doximity by 3.2% during the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after acquiring an additional 537 shares during the period. Institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.